[& E;Vv =*h8]]Ih8 hOpVVh}op LaC wQcw0P- crCxeCC GJ, ~n{y~6{M~ TdYYuvdlPs CT\7\C#T ,d8,&s8r&v &;@ ]F3FW6]63v Rjz+Rm6 FN2 LkRNv[RR u{&b n_&n/;]f_]g %mP1JjP% :@qq X15X_+nA1 O{Cxxu B!W ?_aQ/C[=?_aQ/K)KnaKU7_?n_8 0MS4)yyS 5@#X*=55=vX*J5 {8l]8L[lA. I:e{ =|6} Q~~j )OZ/ naE NUqU\H &6zV oH_tN__HLX_ Yr4mk!$ ]8 &|&daZ]a 8_;_ Txx FZhq o#UoKo)k}w ,V~ ~tP$7 G@@nVx,x{G\6, ora41$-O1r$z kB !cMM NmE Mt|MTmt *~Ph*:Pm*. fD O[$O-y cFh3oqo|+/h [/}{ i,sTg PmF *5UE7 zI 6_Yf\YY viRR2#2wB +b,E&)b AB KOm|z oh8pp8&j{V G%4 5 WJi BG# GnW F@SAY/YEW 99 :ttJY 1/8]h6*3]T8]*3/v L8NLp{l.
Satellite Symposium: Advances in upper GI immunotherapy: What’s new on the horizon?
Overview of the treatment landscape and management options for patients with oesophageal squamous cell carcinoma (ESCC) and gastric/gastro-oesophageal junction adenocarcinoma (GC/GEJC) presented at the ESMO Gastrointestinal Cancers Congress 2024. Watch the recording below.